Regression Rate of Basal Cell Carcinoma in a Veteran Population: A Study of 317 Cases at the Kansas City Veterans Affairs Medical Center.
BCC is a tumor with the potential to regress. However, definitive management resides in complete surgical excision, which will most likely remain the mainstay of treatment in the near future.
Authors
- Daniel Mettman (ORCID: https://orcid.org/0000-0003-1735-8925)
- Margaryta Stoieva
Institutions
- University of Kansas (US)
Publication Details
- Journal
- PubMed
- Published
- 2025-10-01
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00